$11.145
0.315[2.91%]
Last update: 12:17PM Get Real Time Here
Third Harmonic Bio
(NASDAQ:THRD)Third Harmonic Bio Stock (NASDAQ:THRD), Analyst Ratings, Price Targets, Predictions
Third Harmonic Bio Inc has a consensus price target of $3.53, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from Morgan Stanley, Morgan Stanley, and Jefferies on August 11, 2023, December 16, 2022, and December 16, 2022. With an average price target of $5.2 between Morgan Stanley, Morgan Stanley, and Jefferies, there's an implied -54.10% downside for Third Harmonic Bio Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Jefferies
Cowen & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Third Harmonic Bio
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 08/11/2023 | THRD | Buy Now | Third Harmonic Bio | $11.33 | -38.22% | Morgan Stanley | Michael Ulz | $5 → $7 | Maintains | Equal-Weight | Get Alert |
| 12/16/2022 | THRD | Buy Now | Third Harmonic Bio | $11.33 | -55.87% | Morgan Stanley | Michael Ulz | $34 → $5 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/16/2022 | THRD | Buy Now | Third Harmonic Bio | $11.33 | -68.23% | Jefferies | Akash Tewari | $30 → $3.6 | Downgrade | Buy → Hold | Get Alert |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $11.33 | 164.78% | Jefferies | Akash Tewari | → $30 | Initiates | → Buy | Get Alert |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $11.33 | 200.09% | Morgan Stanley | Michael Ulz | → $34 | Initiates | → Overweight | Get Alert |
| 10/10/2022 | THRD | Buy Now | Third Harmonic Bio | $11.33 | — | Cowen & Co. | Joseph Thome | — | Initiates | → Outperform | Get Alert |
FAQ
What is the target price for Third Harmonic Bio (THRD)?
The latest price target for Third Harmonic Bio (NASDAQ: THRD) was reported by Morgan Stanley on August 11, 2023. The analyst firm set a price target for $7.00 expecting THRD to fall to within 12 months (a possible -37.19% downside). 1 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Third Harmonic Bio (THRD)?
The latest analyst rating for Third Harmonic Bio (NASDAQ: THRD) was provided by Morgan Stanley, and Third Harmonic Bio maintained their equal-weight rating.
When was the last upgrade for Third Harmonic Bio (THRD)?
There is no last upgrade for Third Harmonic Bio.
When was the last downgrade for Third Harmonic Bio (THRD)?
The last downgrade for Third Harmonic Bio Inc happened on December 16, 2022 when Morgan Stanley changed their price target from $34 to $5 for Third Harmonic Bio Inc.
When is the next analyst rating going to be posted or updated for Third Harmonic Bio (THRD)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Third Harmonic Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Third Harmonic Bio was filed on August 11, 2023 so you should expect the next rating to be made available sometime around August 11, 2024.
Is the Analyst Rating Third Harmonic Bio (THRD) correct?
While ratings are subjective and will change, the latest Third Harmonic Bio (THRD) rating was a maintained with a price target of $5.00 to $7.00. The current price Third Harmonic Bio (THRD) is trading at is $11.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.